JCT  Vol.6 No.12 , November 2015
Treatment Results of Adjuvant Chemotherapy after Radical Hysterectomy for Intermediate-Risk Stage IB-IIB Cervical Cancer
Objective: The objective is to evaluate the effectiveness of chemotherapy as postoperative adjuvant therapy for stage IB-IIB cervical cancer with intermediate-risk factors. Methods: We retrospectively reviewed the medical records of 119 cervical cancer patients with intermediate-risk factors treated with radical hysterectomy and pelvic lymphadenectomy from December 1997 to September 2010. The intermediate-risk factors included bulky tumor (≥4 cm), lymphovascular space invasion, and deep stromal invasion. Sixteen patients did not receive adjuvant therapy (observation group); 73 were treated with chemotherapy (CT group); 30 were treated with adjuvant radiation therapy (RT group). The significance of the clinical parameters, 3- and 5-year overall survival (OS) rates of each group, was analyzed. Results: The 3- and 5-year OS rates between the observation group and adjuvant therapy group (CT plus RT groups) were not statistically different (3-year OS: 100% and 94.4%, respectively; 5-year OS: 100% and 92.3%, respectively; p > 0.05). The 3- and 5-year OS rates between the CT group and RT group were also not statistically different (3-year OS: 93.6% and 96.4%, respectively; 5-year OS: 80.7% and 96.4%, respectively; p < 0.05). Univariate and multivariate analysis of survival indicated that different adjuvant therapies were not independent prognostic indicators for IB-IIB cervical cancer patients with intermediate-risk factors. Conclusions: CT may have equivalent therapeutic effect as RT for stage IB-IIB cervical cancer patients with intermediate-risk factors after radical surgery, and prospective randomized trial is needed to study the effect of CT in these patients.

Cite this paper
Wen, H. , Liu, T. , Feng, Z. , Huang, W. , Ma, K. and Tao, X. (2015) Treatment Results of Adjuvant Chemotherapy after Radical Hysterectomy for Intermediate-Risk Stage IB-IIB Cervical Cancer. Journal of Cancer Therapy, 6, 1075-1082. doi: 10.4236/jct.2015.612117.
[1]   Nam, J.H., Park, J.Y., Kim, D.Y., et al. (2012) Laparoscopic versus Open Radical Hysterectomy in Early-Stage Cervical Cancer: Long-Term Survival Outcomes in a Matched Cohort Study. Annals of Oncology, 23, 903-911.

[2]   Park, J.Y., Kim, D.Y., Kim, J.H., et al. (2011) Outcomes after Radical Hysterectomy According to Tumor Size Divided by 2-cm Interval in Patients with Early Cervical Cancer. Annals of Oncology, 22, 59-67.

[3]   Song, S., Song, C., Kim, H.J., et al. (2012) 20-Year Experience of Postoperative Radiotherapy in IB-IIA Cervical Cancer Patients with Intermediate Risk Factors: Impact of Treatment Period and Concurrent Chemotherapy. Gynecologic Oncology, 124, 63-67.

[4]   Garg, G., Shah, J.P., Toy, E.P., et al. (2011) Stage IIA1 versus Stage IIA2 Cervical Cancer: Does the New Staging Criteria Predict Survival? International Journal of Gynecological Cancer, 21, 711-716.

[5]   Peters, W.A., Liu, P.Y., Barrett, R.J., et al. (2000) Concurrent Chemotherapy and Pelvic Radiation Therapy Compared with Pelvic Radiation Therapy Alone as Adjuvant Therapy after Radical Surgery in High-Risk Early-Stage Cancer of the Cervix. Journal of Clinical Oncology, 18, 1606-1613.

[6]   Lahousen, M., Haas, J., Pickel, H., et al. (1999) Chemotherapy versus Radiotherapy versus Observation for High-Risk Cervical Carcinoma after Radical Hysterectomy: A Randomized, Prospective, Multicenter Trial. Gynecologic Oncology, 73, 196-201.

[7]   Curtin, J.P., Hoskins, W.J., Venkatraman, E.S., et al. (1996) Adjuvant Chemotherapy versus Chemotherapy plus Pelvic Irradiation for High-Risk Cervical Cancer Patients after Radical Hysterectomy and Pelvic Lymphadenectomy (RH-PLND): A Randomized Phase III Trial. Gynecologic Oncology, 61, 3-10.

[8]   Iwasaka, T., Kamura, T., Yokoyama, M., et al. (1998) Adjuvant Chemotherapy after Radical Hysterectomy for Cervical Carcinoma: A Comparison with Effects of Adjuvant Radiotherapy. Obstetrics & Gynecology, 91, 977-981.

[9]   Takeshima, N., Umayahara, K., Fujiwara, K., et al. (2006) Treatment Results of Adjuvant Chemotherapy after Radical Hysterectomy for Intermediate- and High-Risk Stage IB-IIA Cervical Cancer. Gynecologic Oncology, 103, 618-622.

[10]   Hosaka, M., Watari, H., Takeda, M., et al. (2008) Treatment of Cervical Cancer with Adjuvant Chemotherapy versus Adjuvant Radiotherapy after Radical Hysterectomy and Systematic Lymphadenectomy. The Journal of Obstetrics and Gynaecology Research, 34, 552-556.

[11]   Lee, K.B., Lee, J.M., Ki, K.D., et al. (2008) Comparison of Adjuvant Chemotherapy and Radiation in Patients with Intermediate Risk Factors after Radical Surgery in FIGO Stage IB-IIA Cervical Cancer. International Journal of Gynecological Cancer, 18, 1027-1031.